Insulin resistance is known to be closely related to essential hypertension. It has been hypothesized that abnormal calcium homeostasis both at the cellular level and in the whole body plays a substantial role in hypertension associated with insulin resistance. We attempted to determine the relationships among insulin sensitivity, blood pressure (BP), body mass index (BMI), and calcium-related parameters in young, lean, normotensive male subjects with extreme susceptibilities to hypertension, and to investigate the effects of euglycemic hyperinsulinemia on calcium-related parameters. Seven young, lean, normotensive male subjects with family histories of essential hypertension and 10 age-matched controls without any parental cardiovascular events were enrolled. Insulin sensitivity measurement by the euglycemic hyperinsulinemic clamp technique and a 75-g oral glucose tolerance test were performed. Calcium-related parameters, including intracellular Ca2+ levels in platelets, were measured simultaneously.
Insulin resistance is known to be closely related to essential hypertension. It has been hypothesized that abnormal calcium homeostasis both at the cellular level and in the whole body plays a substantial role in hypertension associated with insulin resistance. We attempted to determine the relationships among insulin sensitivity, blood pressure (BP), body mass index (BMI), and calcium-related parameters in young, lean, normotensive male subjects with extreme susceptibilities to hypertension, and to investigate the effects of euglycemic hyperinsulinemia on calcium-related parameters. Seven young, lean, normotensive male subjects with family histories of essential hypertension and 10 age-matched controls without any parental cardiovascular events were enrolled. Insulin sensitivity measurement by the euglycemic hyperinsulinemic clamp technique and a 75-g oral glucose tolerance test were performed. Calcium-related parameters, including intracellular Ca2+ levels in platelets, were measured simultaneously.
Diastolic BP was inversely correlated with insulin sensitivity in vivo (M-value) . Insulin sensitivity was inversely correlated with BMI and with intracellular Ca2+ in platelets. In the multivariate stepwise regression analysis using both diastolic BP and insulin sensitivity as dependent variables, BMI was found to be a determinant independent variable. Euglycemic hyperinsulinemia decreased intact parathyroid hormone levels and increased fractional excretion of calcium. In conclusion, BMI rather than a family history of hypertension plays a determinant role on the regulation of diastolic BP and insulin sensitivity even in young, lean, normotensive male subjects with extreme predispositionsIntroduction It has been well established that there is a close relationship between insulin resistance and essential hypertension (1-5). Some studies have revealed that insulin resistance is associated with offspring of essential hypertensive patients (6-8). Insulin resistance sometimes exists before the onset of hypertension, and genetically determined insulin resistance and/or compensated hyperinsulinemia may contribute to the development of hypertension (9).
Abnormal Ca2+ transport is associated with several diseases and conditions, such as essential hypertension, diabetes mellitus and obesity (10-13). Insulin resistance also accompanies these conditions. Insulin regulation of vasoconstriction and vasodilatation appears to be secondary to regulation of intracellular Ca2+ ([Ca2+];), as insulin attenuates both voltage-and receptor-mediated Ca2+ influx and stimulates both the transcription and activity of Ca2+-ATPase in vascular smooth muscle cells. FurtherFrom the *Department of Internal Medicine, TEPCO Hospital, Tokyo, Japan, **Department of Internal Medicine, School cine, Keio University, Tokyo, Japan, and ***Department of Internal Medicine, Saitama Medical College, Saitama, Japan. more, these effects are blunted in individuals with insulin resistance.
Although [Ca2+] ; plays a poorly understood role in insulin signalling, increases beyond an optimal range result in impaired insulin sensitivity. Draznin et al. have hypothesized that abnormal intracellular Ca2+ homeostasis is attributable to insulin resistance associated with essential hypertension (10). They demonstrated that increasing
[Ca2+]j in isolated adipocytes results in significant inhibition of insulin-stimulated glucose transport and oxidation. Increased [Ca2+]j may contribute to insulin resistance by inhibiting the dephosphorylation of the insulin-sensitive glucose transporter and thereby decreasing its activity (14). Our previous study concerning the relationship between insulin sensitivity and [Ca2+]j in platelets supported this hypothesis (6). Although insulin resistance and disturbed Ca2+ metabolism are closely linked in vivo, only a few studies have attempted to investigate the relationship between insulin sensitivity/hyperinsulinemia and wholebody calcium homeostasis (15, 16) .
In the present study, we investigated the relationship between insulin sensitivity and whole-body calcium metabolism, and examined the effects of hyperinsulinemia on calcium-related factors in young, lean, normotensive male subjects who displayed extreme predispositions for the development of hypertension.
Subjects and Methods

Subjects
Seven, young, lean, normotensive males with a positive family history of hypertension and cardiovascular diseases were recruited. One parent of each subject was either hypertensive with blood pressure (BP) > 160/95 mmHg or was receiving antihypertensive medication; secondary forms of hypertension were excluded by usual clinical investigations. In addition, at least one grandparent of each subject was asserted either to be hypertensive or to have experienced cardiovascular complications, or both. As normal controls, 10 young, lean, normotensive males without family histories of hypertension or cardiovascular diseases were recruited. The results of recent annual health checks were used to confirm that none of the candidates were hypertensive (< 140/90 mmHg). Candidates with a diabetic or obese (body mass index (BMI) >30 kg/m2) parent were excluded. The family history was assessed by measuring the BP of the parents at an outpatient clinic and by information obtained from direct personal communication with their physicians. All subjects were volunteers, on an unrestricted diet, and written informed consent was obtained from each prior to the investigations.
Euglycemic Hyperinsulinemic
Clamp Technique BP was measured using a mercury sphygmomanometer with the subject in a supine position following a 15-min rest, and was expressed as the mean of three consecutive measurements. The sensitivity to insulin was determined by the euglycemic hyperinsulinemic clamp technique as previously described (6, 17) . Briefly, all studies began at 9;00 AM after an overnight fast. An angiocatheter was placed in the median cubital vein of the left forearm for infusion, and a second double lumen angiocatheter was placed retrogradely in the superficial radial vein of the right wrist. A blood sample was drawn for determination of fasting glucose, fasting immunoreactive insulin (IRI), calcium-related parameters, and blood chemistry including electrolytes and plasma lipids. An insulin `prime' was infused manually over a 10-min period, followed by constant infusion of 1 mU/kg/min for 110 min by a Biostator (Biostator GCIIS 4990; Miles Inc., Elkhart, IN). Euglycemia was maintained by variable infusion of a 20% glucose solution. This was done so that the glucose infusion rate would reflect the total insulin-stimulated glucose metabolism during steady-state hyperinsulinemia. The quantity of exogenous glucose metabolized was calculated from the mean of the glucose infusion rate during the second hour of hyperinsulinemia (M-value) . At the end of 2-h euglycemic hyperinsulinemic clamping, a blood sample was drawn for measurements of glucose, IRI levels, electrolytes, and calcium-related parameters. A 75-g oral glucose tolerance test was performed a few weeks later in all subjects. The daily dietary intake was ascertained by interview, and the energy consumption was assessed based on reported physical activity.
Measurements
[Ca2+]j in platelets was measured using Fura-2 as previously described (6, 18). IRI was assayed in plasma using a commercial radioimmunoassay kit (Phadeseph Insulin RIA; Pharmacia, Uppsala, Sweden). Triglycerides and cholesterol were measured by an enzymatic technique. The total calcium and potassium were measured with an autoanalyzer (System E4A; Beckman Instruments, Inc., La Brea, CA). Samples for measurement of plasma ionized calcium were collected anaerobically in 3-ml tubes and assayed using an ion-selective electrode (Nova 8; Nova Biochemical, Newton, MA). The serum intact parathyroid hormone (PTH) level was measured by radioimmunoassay (Nicholas Inst. Diagnostics, San Juan Capistrano, CA). 1,25-dihydroxyvitamin D3((OH)2-D3) was assayed by the radioreceptor method (Mitsubishi Yuka Bioclinical Laboratories, Tokyo, Japan). Fractional excretion of calcium (FECa) was calculated as (urinary calcium X serum creatinine)/(serum calcium X urinary creatinine).
Analytical Methods
Values are expressed as means ± SEM. Because no evidence of non-normal distribution or inequality of variances was present in the variables considered, statistical comparisons were performed using either a paired or unpaired two-tailed Student's t-test, or analysis of variance (ANOVA) with repeated measurements, as appropriate. Pearson's correlation was used to assess the relationship between the variables. P values less than 0.05 were considered to indicate statistical significance. Multiple linear regression analysis was used to define the relative importance of the clinical and metabolic variables for diastolic BP and insulin sensitivity (M-value) . The Statistical Package of Social Science (SPSS) for Windows, version 7.51, was used for statistical analyses.
Results
Clinical Characteristics
No significant differences in age, BMI, systolic BP or diastolic BP were observed between subjects with a positive family history of essential hypertension and controls (Table 1) . Glucose concentration and IRI levels, as revealed by the oral glucose tolerance test, were also similar between the experimental subjects and controls (Table  2) , as were the lipid profiles, including total cholesterol, triglycerides and HDL-cholesterol, and the daily dietary intake and energy consumption related to physical activity. Insulin sensitivity (M-value) tended to be impaired in subjects with a family history of hypertension (6.90±0.40 vs. 8.75 ±0.79, p=0.08, unpaired t-test) ( Table 3 ). The level of [Ca2+]i in platelets was significantly higher in subjects with a positive than in those with a negative family history of hypertension (116 ± 3 vs. 101 ± 2 nmol/1, p < 0.001, unpaired t-test) (Table 4) . Thrombin-stimulated [Ca2 j tended to be higher in those with a positive than in those with a negative family history (871 ± 71 vs. 705 ± 50 nmol/l, p=0.07, unpaired t-test). FEca before the insulin sensitivity test by the euglycemic hyperinsulinemic clamp technique was significantly lower in those with a positive than in those with a negative family history (0.57 ± 0.13 vs. 0.99 ± 0. 12, p < 0.05, unpaired t-test).
Effects of Hyperinsulinemia on Glucose Metabolism
In all subjects, euglycemic hyperinsulinemic clamping maintained plasma glucose at the basal level and increased IRI levels markedly from 6±1 to 54±4 ,~U/ml (p <0.0001, ANOVA with repeated measurements). Serum K was slightly but significantly decreased from 3.9±0.1 to 3.7 ± 0.1 mmol/l by euglycemic hyperinsulinemic clamping (p< 0.05, ANOVA with repeated measurements), and tended to be higher in subjects with positive than in those with negative family history (p=0.08, ANOVA with repeated measurements) ( Table 2) , whereas serum Na, Ca and Cl neither changed significantly nor differed significantly between the groups.
Effects of Hyperinsulinemia on Calcium Homeostasis
Hyperinsulinemic clamping significantly decreased the intact PTH level from 40 ± 4 to 29 ± 2 pg/ml (p< 0.05, ANOVA with repeated measurements) and raised FEca from 0.80 ± 0.10 to 1.23 ± 0.17 (p < 0.05, ANOVA with repeated measurements) ( Table 4) . 
Relationship between Insulin Sensitivity and Calcium Homeostasis
Insulin sensitivity (M-value) was inversely correlated with BMI (r=-0.612, p<0.01, Fig. 2a ) and with [Ca2+]; in platelets (r= -0.598, p<0.01, Fig. 2b ), but was not sig- nificantly correlated with differences between the pre-and postclamping levels of serum Ca, intact PTH, (OH)2-D3, or FEca. Furthermore, insulin sensitivity was not significantly correlated with differences between the pre-and postclamping levels of serum K. Nor were the changes in IRI levels by clamping significantly correlated with those of any other factors.
Multiple Regression Analysis between Diastolic Blood Pressure or Insulin Sensitivity and Metabolic and Clinical Variables
In the stepwise multivariate regression analysis, diastolic BP and insulin sensitivity (M-value) were used as the dependent variables and the following as independent variables: family history of essential hypertension, BMI, insulin sensitivity (M-value) , sigma IRI during the oral glucose tolerance test, basal [Ca2+]i in platelets, and FEca before clamping, appropriately. Positive and negative family histories of essential hypertension were categorized as 1 and 0, respectively. The best multivariate regression models were those in which diastolic BP= 17.1 + 1.94X BMI (r=0.63, F=10.1, p=0.006) and insulin sensitivity 
Discussion
This study provides evidence of a close relationship between insulin resistance, BMI, Ca2+-related parameters and BP in young, lean, normotensive male subjects with extreme susceptibilities to hypertension. Increased [Ca2+]i in platelets was associated with subjects who had a positive family history of hypertension. Euglycemic hyperinsulinemia in the physiological range significantly decreased intact PTH levels and significantly increased FEca. Diastolic BP was correlated with BMI. Insulin sensitivity was inversely correlated with BMI and with [Ca2+]i in platelets. In the multivariate regression analysis, both diastolic BP and insulin sensitivity were predominantly related to BMI. Therefore, a slight increase in body weight might contribute to BP elevation and insulin resistance in the very early phase of genetic hypertension. (21) . In our preliminary study, we did not observe any change of [Ca2+]i in platelets by euglycemic hyperinsulinemia or in vitro coincubation of insulin within the range of physiological concentrations (6). Therefore, the effects of insulin on ionized calcium and [Ca2+]i have been controversial, and the question of whether the response to insulin might vary according to insulin resistant status or experimental conditions has been raised.
Relationship between Insulin Sensitivity and Calcium Homeostasis
In the present study, insulin sensitivity (M-value) was inversely correlated with [Ca2+]i in platelets (r=-0.598, p<0.01) and with BMI (r=-0.612, p<0.01). Increased [Ca2+]i in platelets was associated with a positive family history of hypertension. Diastolic BP was correlated with BMI (r=0.634, p<0.01). Therefore, even in the very early phase of essential hypertension, a slight increase in body weight associated with abnormal cellular Ca2+ transport might contribute to insulin resistance and elevation of BP. Williams et al. proposed that the effects of excess body weight should be considered in investigating the role of [Ca2+]i in platelets in the pathogenesis of hypertension, based on the data from 109 twin pairs (22) . Pioneer studies suggested that BP was correlated with [Ca2+]i in platelets in essential hypertension (23, 24) . Some studies on normotensive offspring indicate that disturbed calcium homeostasis, including increased [Ca2+]i in platelets, is associated with a family history of hypertension, although BP is not always correlated with [Ca2+]i (6, 18, 22, 25) . We propose that increased [Ca2+]i in platelets could be a genetic marker of abnormal calcium homeostasis in the subjects with a positive family history of essential hypertension. In the logistic regression analysis of the offspring of individuals with essential hypertension, Mino et al. reported glucose to insulin ratio and on serum insulin levels after oral glucose loading (26) . They suggested that insulin resistance was more closely related to obesity, but not to a family history of hypertension. In our multivariate regression analysis, both diastolic BP and insulin sensitivity were predominantly related to BMI. Even in these young, lean, normotensive male subjects with extreme predispositions for the development of hypertension, BMI played a determinant role in the regulation of diastolic BP and insulin sensitivity. Although a large number of studies have confirmed the close linkage between insulin resistance and essential hypertension (1-5), it remains unclear whether insulin resistance or compensatory hyperinsulinemia can be attributed to increases in BP. Recently, the so-called `selective insulin resistance' hypothesis has been proposed .
In this hypothesis, the action of insulin is assumed to be enhanced to be consistent with compensatory hyperinsulinemia in the BP regulatory tissues, although insulin resistance of glucose regulatory tissues, such as skeletal muscle and adipose tissue, is associated with essential hypertension. However, the results of this study did not support the hypothesis, because no evidence of `selective insulin resistance' in relation to calcium homeostasis was detected. The changes in PTH and FE~a by 2-h clamping were similar in insulin-resistant and insulin-sensitive subjects. The changes in PTH and FE~a were correlated neither with the changes in IRI levels nor with insulin sensitivity. These findings, however, may have been due to the small number of subjects studied, which may not have allowed detection of slight differences between the insulinresistant and insulin-sensitive groups.
In conclusion, BMI rather than a family history of hypertension plays a determinant role on the regulation of diastolic BP and insulin sensitivity even in young, lean, normotensive male subjects with extreme predispositions for the development of hypertension. Further detailed studies must be conducted in order to elucidate how slight increases in body weight impair insulin sensitivity and elevate BP. Larger prospective studies will elucidate whether BMI or a family history of hypertension is the major determinant in the future development of hypertension. 
